140 related articles for article (PubMed ID: 18841367)
1. [Development of molecular-pathologic entities of colorectal cancer].
Kirchner T; Reu S
Pathologe; 2008 Nov; 29 Suppl 2():264-9. PubMed ID: 18841367
[TBL] [Abstract][Full Text] [Related]
2. [Serrated pathway of colorectal carcinogenesis].
Baretton GB
Pathologe; 2010 Feb; 31(1):9-15. PubMed ID: 19921196
[TBL] [Abstract][Full Text] [Related]
3. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
Bae JM; Kim JH; Kang GH
Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
Ruemmele P; Dietmaier W; Terracciano L; Tornillo L; Bataille F; Kaiser A; Wuensch PH; Heinmoeller E; Homayounfar K; Luettges J; Kloeppel G; Sessa F; Edmonston TB; Schneider-Stock R; Klinkhammer-Schalke M; Pauer A; Schick S; Hofstaedter F; Baumhoer D; Hartmann A
Am J Surg Pathol; 2009 May; 33(5):691-704. PubMed ID: 19252434
[TBL] [Abstract][Full Text] [Related]
6. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.
Lanza G; Gafà R; Matteuzzi M; Santini A
J Clin Oncol; 1999 Aug; 17(8):2429-38. PubMed ID: 10561306
[TBL] [Abstract][Full Text] [Related]
7. [Histological types and prognostic factors in colorectal cancer].
Selves J
Med Sci (Paris); 2009 Mar; 25 Spec No 1():9-12. PubMed ID: 19361404
[TBL] [Abstract][Full Text] [Related]
8. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
9. Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis.
Mäkinen MJ; George SM; Jernvall P; Mäkelä J; Vihko P; Karttunen TJ
J Pathol; 2001 Mar; 193(3):286-94. PubMed ID: 11241406
[TBL] [Abstract][Full Text] [Related]
10. Colorectal serrated adenocarcinoma.
Mäkinen MJ
Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
[TBL] [Abstract][Full Text] [Related]
11. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
13. Serrated polyps and colorectal cancer: new pathway to malignancy.
Noffsinger AE
Annu Rev Pathol; 2009; 4():343-64. PubMed ID: 19400693
[TBL] [Abstract][Full Text] [Related]
14. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer.
Tuppurainen K; Mäkinen JM; Junttila O; Liakka A; Kyllönen AP; Tuominen H; Karttunen TJ; Mäkinen MJ
J Pathol; 2005 Nov; 207(3):285-94. PubMed ID: 16177963
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
[TBL] [Abstract][Full Text] [Related]
16. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT
Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896
[TBL] [Abstract][Full Text] [Related]
17. What influences preneoplastic colorectal lesion recurrence?
De Maio G; Zama E; Rengucci C; Calistri D
Oncotarget; 2017 Feb; 8(7):12406-12416. PubMed ID: 27902488
[TBL] [Abstract][Full Text] [Related]
18. Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases.
Knox RD; Luey N; Sioson L; Kedziora A; Clarkson A; Watson N; Toon CW; Cussigh C; Pincott S; Pillinger S; Salama Y; Evans J; Percy J; Schnitzler M; Engel A; Gill AJ
Ann Surg Oncol; 2015 Sep; 22(9):2988-96. PubMed ID: 25572685
[TBL] [Abstract][Full Text] [Related]
19. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
Young J; Jass JR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
[TBL] [Abstract][Full Text] [Related]
20. [Serrated lesions and carcinoma of colorectum].
Lai MD
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):65-7. PubMed ID: 16630477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
